Unknown

Dataset Information

0

MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application.


ABSTRACT: There are still major challenges regarding the early diagnosis and treatment of chronic kidney disease (CKD), which is in part due to the fact that its pathophysiology is very complex and not clarified in detail. The diagnosis of CKD commonly is made after kidney damage has occurred. This highlights the need for better mechanistic insight into CKD as well as improved clinical tools for both diagnosis and treatment. In the last decade, many studies have focused on microRNAs (miRs) as novel diagnostic tools or clinical targets. MiRs are small non-coding RNA molecules that are involved in post-transcriptional gene regulation and many have been studied in CKD. A wide array of pre-clinical and clinical studies have highlighted the potential role for miRs in the pathogenesis of hypertensive nephropathy, diabetic nephropathy, glomerulonephritis, kidney tubulointerstitial fibrosis, and some of the associated cardiovascular complications. In this review, we will provide an overview of the miRs studied in CKD, especially highlighting miR-103a-3p, miR-192-5p, the miR-29 family and miR-21-5p as these have the greatest potential to result in novel therapeutic and diagnostic strategies.

SUBMITTER: Peters LJF 

PROVIDER: S-EPMC7555601 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application.

Peters Linsey J F LJF   Floege Jürgen J   Biessen Erik A L EAL   Jankowski Joachim J   van der Vorst Emiel P C EPC  

International journal of molecular sciences 20200907 18


There are still major challenges regarding the early diagnosis and treatment of chronic kidney disease (CKD), which is in part due to the fact that its pathophysiology is very complex and not clarified in detail. The diagnosis of CKD commonly is made after kidney damage has occurred. This highlights the need for better mechanistic insight into CKD as well as improved clinical tools for both diagnosis and treatment. In the last decade, many studies have focused on microRNAs (miRs) as novel diagno  ...[more]

Similar Datasets

| S-EPMC7423998 | biostudies-literature
| S-EPMC5499684 | biostudies-literature
| S-EPMC5622146 | biostudies-literature
| S-EPMC2887501 | biostudies-literature
| S-EPMC5860815 | biostudies-literature
| S-EPMC8056970 | biostudies-literature
| S-EPMC4254470 | biostudies-other
| S-EPMC4897719 | biostudies-other
| S-EPMC5469576 | biostudies-literature
| S-EPMC8506855 | biostudies-literature